Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › unfractionated heparin

unfractionated heparin

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of unfractionated heparin

9 trials tracked of unfractionated heparin: 5 in phase 3 or 4 and 4 with published results. The most-cited published study has 1113 citations.

9Trials tracked
5Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 2 Phase 3 3 Phase 2 4
  1. Phase 3 ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism Completed · 1,113 cited
  2. Phase 3 Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH Completed · 122 cited
  3. Phase 3 Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Completed · 58 cited
  4. Phase 4 Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO Completed · 12 cited
  5. Phase 4 How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention Completed
  6. Phase 2 Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention Completed
Show 3 more trials
  1. Phase 2 Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) Completed
  2. Phase 2 The Randomized OPTIMAL-ACT Trial Completed
  3. Phase 2 Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.